Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This pilot study aims to evaluate Maraviroc intensification strategy during 24 weeks in HIV
infected patients under efficient (CV< 50 cp/mL), controlled antiretroviral therapy (≥ 6
months) and uncompleted immune restoration (CD4<350 cells/mL and CD4 earning <100 cells/mL
during last 24 months).
The study will include 60 patients whose follow up is carried out for 48 weeks. recruitment
period will be maintained for 12 months.
Phase:
Phase 2
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis